A collaborative study by the UN Technology Bank, Medtronic and WIPO examines how the MedTech sector can tackle the rising burden of non-communicable diseases, which account for over 70% of global deaths. Through fieldwork in Bangladesh and Rwanda, researchers analyzed innovation culture, intellectual property systems, regulations, financing and policies to identify barriers and enablers of MedTech development in least developed countries (LDCs).
- Acknowledgments
- Executive summary
-
Introduction
The report applies the triple helix model to assess MedTech innovation enablers and barriers in least developed countries, using literature, stakeholder interviews, and case studies in Bangladesh and Rwanda, coordinated by WIPO, the UN Technology Bank, and Medtronic.
-
Main challenges and enablers in the MedTech sector in LDCs
This section examines challenges and enablers in areas of IP, regulation, finance, and capacity in LDCs from public and private sectors. It highlights that governments, academic institutions and private companies influence MedTech innovation through policy, funding, and the triple helix model.
-
Bangladesh case study
This case study captures national laws and policies, institutional and academic research, and stakeholder insights from government agencies, hospitals, the Medtech industry, academia, and IP and innovation experts to identify Bangladesh-specific opportunities and recommendations.
-
Rwanda case study
This case study captures national and regional laws and policies, institutional and academic research, and stakeholder insights from government agencies, hospitals, innovation hubs, advocacy groups, digital health firms, MedTech companies, and IP and innovation experts to identify Rwanda-specific MedTech opportunities and recommendations.
- Lessons learned: applicable to all LDCs
- Country-specific opportunities and recommendations
- Study limitations and areas for further research
- Annex 1. Open-ended interview questions
- Annex 2. Interviewee profiles
- Copyright
